Sanofi is of REGENERON PHARMACEUTICALS, INC.. Currently has a direct ownership of 0 shares of REGN, which is worth approximately $0. The most recent transaction as insider was on May 29, 2020, when has been sold 20,421,899 shares (Common Stock) at a price of $509.85 per share, resulting in proceeds of $10,412,105,330. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Sanofi Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 29 2020
SELL
Open market or private sale
$10,412,105,330 $509.85 p/Share
20,421,899 Reduced 100.0%
0 Common Stock
Mar 09 2020
SELL
Open market or private sale
$63,122,739 $489.65 p/Share
128,914 Reduced 0.63%
20,421,899 Common Stock
Sep 10 2019
SELL
Open market or private sale
$48,611,959 $281.15 p/Share
172,904 Reduced 0.83%
20,550,813 Common Stock
Mar 08 2019
SELL
Open market or private sale
$54,041,671 $412.17 p/Share
131,115 Reduced 0.63%
20,723,717 Common Stock

Also insider at

CHTT
CHATTEM INC
GENZ
GENZYME CORP
HGEN
HUMANIGEN, INC Healthcare
RGLS
Regulus Therapeutics Inc. Healthcare
ALNY
ALNYLAM PHARMACEUTICALS, INC. Healthcare
MYOK
MyoKardia Inc
VYGR
Voyager Therapeutics, Inc. Healthcare
FULC
Fulcrum Therapeutics, Inc. Healthcare
ICVX
Icosavax, Inc. Healthcare
INZY
Inozyme Pharma, Inc. Healthcare
TBIO
Translate Bio, Inc. Healthcare
S

Sanofi

Paris, I0

Track Institutional and Insider Activities on REGN

Follow REGENERON PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells REGN shares.

Notify only if

Insider Trading

Get notified when an Regeneron Pharmaceuticals, Inc. insider buys or sells REGN shares.

Notify only if

News

Receive news related to REGENERON PHARMACEUTICALS, INC.

Track Activities on REGN